# Axithra

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/axithra-b-v

- Industry: Medical Devices & Equipment
- Headquarters: Gent, Belgium
- Website: www.axithra.com
- Total disclosed funding: $11M
- Latest round: Seed (Aug 1, 2023)
- Investors on record: 9

## About

Established in 2023 and based in Belgium, Axithra B.V. is a spin-off of Imec and Ghent University that operates as a developer of therapeutic drug monitoring devices. In September 2023, Axithra raised EUR 10 million in seed funding from imec.xpand and Kurma Partners, including Qbic, Noshaq, White Fund, Wallonie Entreprendre, Hamamatsu Photonics, and Werfen Diagnostics. As of 2023, Leander Van Nest serves as the CEO of the company.

The company provides a therapeutic drug monitoring (TDM) device that measures drug concentrations in patient’s blood. The firm’s platform is customizable for medication for each unique patient, even under changing conditions and in a variety of settings, including outside of the hospital lab.

The organization plans to use the September 2023 funding to speed up its launch in the market.

## Funding rounds

- Seed, Aug 1, 2023, $11M — Kurma Partners, Qbic Fund, Noshaq, Hamamatsu Photonics K.K., Imec.xpand, Ghent University, White Fund, Werfen, Wallonie Entreprendre

## Investors

- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Seed
- Qbic Fund (https://capitalatlas.ai/funds/qbic-fund) — Seed
- Noshaq (https://capitalatlas.ai/funds/noshaq) — Seed
- Hamamatsu Photonics K.K. — Seed
- Imec.xpand (https://capitalatlas.ai/funds/imec-xpand) — Seed
- Ghent University — Seed
- White Fund (https://capitalatlas.ai/funds/white-fund) — Seed
- Werfen — Seed
- Wallonie Entreprendre — Seed